GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 392 filers reported holding GLOBUS MED INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,315 | +1828.6% | 136 | +1411.1% | 0.00% | – |
| Q1 2024 | $483 | +0.6% | 9 | 0.0% | 0.00% | – |
| Q4 2023 | $480 | -75.2% | 9 | -76.9% | 0.00% | – |
| Q3 2023 | $1,936 | +225.4% | 39 | +290.0% | 0.00% | – |
| Q2 2023 | $595 | -4.5% | 10 | -9.1% | 0.00% | – |
| Q1 2023 | $623 | -94.4% | 11 | -92.7% | 0.00% | -100.0% |
| Q4 2022 | $11,215 | +40.2% | 151 | +6.3% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +700.0% | 142 | +468.0% | 0.00% | – |
| Q2 2022 | $1,000 | -95.2% | 25 | -91.2% | 0.00% | -100.0% |
| Q1 2022 | $21,000 | +950.0% | 284 | +1036.0% | 0.00% | – |
| Q4 2021 | $2,000 | -80.0% | 25 | -80.0% | 0.00% | -100.0% |
| Q3 2021 | $10,000 | -9.1% | 125 | -13.8% | 0.00% | +50.0% |
| Q2 2021 | $11,000 | +37.5% | 145 | +16.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +33.3% | 125 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 327,723 | $13,863,000 | 7.09% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 944,700 | $39,960,000 | 3.64% |
| Godshalk Welsh Capital Management, Inc. | 85,108 | $3,600,000 | 3.33% |
| NUANCE INVESTMENTS, LLC | 1,316,057 | $55,669,000 | 2.36% |
| Global Alpha Capital Management Ltd. | 264,350 | $11,182,000 | 1.94% |
| BROADVIEW ADVISORS LLC | 147,275 | $6,230,000 | 1.92% |
| Van Berkom & Associates Inc. | 1,476,695 | $62,464,000 | 1.81% |
| Pembroke Management, LTD | 319,037 | $13,495,000 | 1.42% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $8,460,000 | 1.28% |
| OAK RIDGE INVESTMENTS LLC | 408,731 | $17,289,000 | 1.20% |